• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AUTL

AUTL

Autolus Therapeutics plc

NASDAQHealthcareBiotechnologyGB

USD1.62

-0.13 (-7.43%)

Rating:D+

Company Profile

CEO

Christian Martin Itin

IPO Date

2018-06-22

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

GB

Market Metrics

Open

$1.78

Prev. Close

$1.75

Day Low

$1.59

Day High

$1.78

52W Low

$1.18

52W High

$2.70

Market Cap

$0.43B

Volume

2.05M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

58.3%

Avg Negative

2.7%

Avg Neutral

39.2%

News Feed

Autolus Therapeutics plc (AUTL) CEO Christian Itin on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/7/2021·↓ negative

Here's Why Autolus Therapeutics Is Surging Today

The Motley Fool·8/2/2021·↑ positive

AUTL Stock Increases Over 15% Pre-Market: Why It Happened

Pulse2·8/2/2021·↑ positive

Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021

GlobeNewsWire·7/8/2021·↓ negative

Autolus Therapeutics Presents New Data on obe-cel in r/r Indolent B Cell Lymphomas and gives an update of obe-cel in r/r Adult ALL at the European Hematology Association Virtual Congress

GlobeNewsWire·6/11/2021·↑ positive

Autolus Therapeutics Announces an Additional Nature Publication for AUTO1

GlobeNewsWire·5/25/2021·↑ positive

Autolus Notice of Annual General Meeting (AGM) on Friday, June 18, 2021

GlobeNewsWire·5/21/2021·↓ negative

Autolus Therapeutics PLC Sponsored ADR (AUTL) Moves 35.5% Higher: Will This Strength Last?

Zacks Investment Research·5/13/2021·↑ positive

Why Autolus Therapeutics Stock Skyrocketed Today

The Motley Fool·5/12/2021·↑ positive

Autolus Therapeutics to Present New Data on AUTO1 in r/r Indolent B Cell Lymphomas at the European Hematology Association Virtual Congress

GlobeNewsWire·5/12/2021·↑ positive